Concert Pharmaceuticals Inc. (CNCE) Slipped -7.25% or -1.12 To Price $14.38 On Monday


Concert Pharmaceuticals Inc. (CNCE) slipped -7.25% or -1.12 to $14.38. It is near 264701 shares traded, which is 153.26% compare to the average total volume 172717. The market cap of CNCE is $338.47 million. The year to date change is 7.04%. The 52 week price range is from $10.8 to $23.17. Price of CNCE have changed -7.51% during last week. It have changed 4.80% over last month, 29.79% over last 3 months, 12.31% over last 6 months and -31.82% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCE is 14.96. It is 4.03% above current price. The 200-day Moving Averages for CNCE is 15.25. It is 6.05% above current price. The 52-week High is 23.17. It is 61.13% from the current price. The 52-week Low is 10.8. It is -24.90% from current price.

There are some statistics of CNCE. It is has market cap $338.47 million. The share outstanding is 23.53 million. The average volume is 172717. The percent of top 15 Institution holding is 96.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCE is -30.77%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCE is -27.72%.


Tags:

Share this post